Literature DB >> 26017843

Reduction in ephedra poisonings after FDA ban.

Michele Zell-Kanter1, Meghan A Quigley, Jerrold B Leikin.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26017843     DOI： 10.1056/NEJMc1502505

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Development of a Genus-Universal Nucleotide Signature for the Identification and Supervision of Ephedra-Containing Products.

Authors:  Gang Wang; Xuanjiao Bai; Xiaochen Chen; Ying Ren; Jianping Han
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

Review 2.  Clinical Implications of Herbal Supplements in Conventional Medical Practice: A US Perspective.

Authors:  Gashaw Hassen; Gizeshwork Belete; Keila G Carrera; Rosemary O Iriowen; Haimanot Araya; Tadesse Alemu; Nebiyou Solomon; Diwas S Bam; Sophia M Nicola; Michael E Araya; Tadesse Debele; Michlene Zouetr; Nidhi Jain
Journal:  Cureus       Date:  2022-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.